2004•Lung CancerRequires access

Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small cell lung cancer: a Kansai Clinical Oncology Group study

Masataka Hirabayashi, Kazuo Endoh, Masayoshi Teramachi, Masato Okuda, Kazuyuki Yamaguchi, Kohji Fukuda, Hidetoshi Tokuhisa, Hitoshi Kagioka, Naoharu Nakai, Masaharu Nakade

Open publisher page 20 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Carboplatin, Medicine, Regimen, Lung cancer, Neutropenia, Internal medicine, Chemotherapy, Paclitaxel

Back to paper search Browse research topics Original source

Phase II study of carboplatin and weekly paclitaxel combination chemotherapy in advanced non-small cell lung cancer: a Kansai Clinical Oncology Group study — Research Paper | ScholarLens